Interferon-gamma enhances radiation-induced cell death via downregulation of Chk1

Cancer Biology and Therapy

Volumn 13, Issue 11, 2012, Pages 1018-1025

  Kim, Kwang Seok ^a   Choi, Kyu Jin ^a   Bae, Sangwoo ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Cancer cell death; Chk1; IFN ; Ionizing radiation; Radiosensitization; XAF1

Indexed keywords

CHECKPOINT KINASE 1; GAMMA INTERFERON; PROTEIN P53; SMALL INTERFERING RNA; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; ATTENUATION; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CORRELATION ANALYSIS; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; PROTEIN STABILITY; RADIOSENSITIVITY; TIME;

CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOWN-REGULATION; HELA CELLS; HUMANS; INTERFERON-GAMMA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN KINASES; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84865843204     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.20990     Document Type: Article

References (36)

1. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202:8-32; PMID:15546383; http://dx.doi.org/10.1111/j.0105-2896.2004.00204.x.
2. Leon ML, Zuckerman SH. Gamma interferon: a central mediator in atherosclerosis. Inflamm Res 2005; 54:395-411; PMID:16283107; http://dx.doi.org/10.1007/s00011-005-1377-2.
3. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003; 8:237-49; PMID:12766484; http://dx.doi.org/10.1023/A:1023668705040.
4. Chawla-Sarkar M, Leaman DW, Borden EC. Preferential induction of apoptosis by interferon (IFN) beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res 2001; 7:1821-31; PMID:11410525.
5. Morrison BH, Bauer JA, Kalvakolanu DV, Lindner DJ. Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells. J Biol Chem 2001; 276:24965-70; PMID:11337497; http://dx.doi.org/10.1074/jbc.M101161200.
6. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, Gilbert JR, et al. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997; 272:16351-7; PMID:9195941; http://dx.doi.org/10.1074/jbc.272.26.16351.
7. Lee SH, Kim JW, Lee HW, Cho YS, Oh SH, Kim YJ, et al. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene 2003; 22:381-91; PMID:12545159; http://dx.doi.org/10.1038/sj.onc.1206133.
8. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferongamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89; PMID:14525967; http://dx.doi.org/10.1189/jlb.0603252.
9. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, Fu XY. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996; 272:719-22; PMID:8614832; http://dx.doi.org/10.1126/ science.272.5262.719.
10. Prasanna SJ, Saha B, Nandi D. Involvement of oxidative and nitrosative stress in modulation of gene expression and functional responses by IFNgamma. Int Immunol 2007; 19:867-79; PMID:17606979; http://dx.doi.org/10.1093/intimm/ dxm058.
11. Kim KS, Kang KW, Seu YB, Baek SH, Kim JR. Interferongamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech Ageing Dev 2009; 130:179-88; PMID:19071156; http://dx.doi.org/10.1016/j.mad.2008.11.004.
12. Tapia-Alveal C, Calonge TM, O'Connell MJ. Regulation of chk1. Cell Div 2009; 4:8; PMID:19400965; http://dx.doi.org/10.1186/1747-1028-4-8.
13. Zhang YW, Otterness DM, Chiang GG, Xie W, Liu YC, Mercurio F, et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell 2005; 19:607-18; PMID:16137618; http://dx.doi.org/10.1016/j. molcel.2005.07.019.
14. Wilsker D, Petermann E, Helleday T, Bunz F. Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control. Proc Natl Acad Sci USA 2008; 105:20752-7; PMID:19091954; http://dx.doi.org/10.1073/pnas. 0806917106.
15. Tian H, Faje AT, Lee SL, Jorgensen TJ. Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways. Neoplasia 2002; 4:171-80; PMID:11896572; http://dx.doi.org/10.1038/sj.neo. 7900219.
16. Suganuma M, Kawabe T, Hori H, Funabiki T, Okamoto T. Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation. Cancer Res 1999; 59:5887-91; PMID:10606229.
17. Kawabe T. G2 checkpoint abrogators as anticancer drugs. Mol Cancer Ther 2004; 3:513-9; PMID:15078995.
18. Mukhopadhyay UK, Senderowicz AM, Ferbeyre G. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells. Cancer Res 2005; 65:2872-81; PMID:15805289; http://dx.doi.org/10.1158/0008-5472.CAN-04-2502.
19. Hobeika AC, Etienne W, Torres BA, Johnson HM, Subramaniam PS. IFNgamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis. J Interferon Cytokine Res 1999; 19:1351-61; PMID:10638704; http://dx.doi.org/10.1089/107999099312812.
20. Ashwell S, Zabludoff S. DNA damage detection and repair pathways - recent advances with inhibitors of checkpoint kinases in cancer therapy. Clin Cancer Res 2008; 14:4032-7; PMID:18593978; http://dx.doi.org/10.1158/1078-0432.CCR-07- 5138.
21. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000; 14:1448-59; PMID:10859164.
22. Chandris P, Giannouli CC, Panayotou G, Kletsas D. Compromise in mRNA processing machinery in senescent human fibroblasts: implications for a novel potential role of Phospho-ATR (ser428). Biogerontology 2010; 11:421-36; PMID:20084458; http://dx.doi.org/10.1007/s10522-010-9261-z.
23. Leung-Pineda V, Huh J, Piwnica-Worms H. DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res 2009; 69:2630-7; PMID:19276361; http://dx.doi.org/10.1158/ 0008-5472.CAN-08-3382.
24. Wang J, Gu Q, Li M, Zhang W, Yang M, Zou B, et al. Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer. Carcinogenesis 2009; 30:1507-16; PMID:19628579; http://dx.doi.org/10.1093/carcin/bgp155.
25. Wang J, Zhang W, Zhang Y, Chen Y, Zou B, Jiang B, et al. c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer. Carcinogenesis 2009; 30:222-9; PMID:19056926; http://dx.doi.org/10.1093/carcin/bgn271.
26. Paulsen RD, Cimprich KA. The ATR pathway: fine-tuning the fork. DNA Repair (Amst) 2007; 6:953-66; PMID:17531546; http://dx.doi.org/10.1016/j.dnarep. 2007.02.015.
27. Xiao Z, Chen Z, Gunasekera AH, Sowin TJ, Rosenberg SH, Fesik S, et al. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem 2003; 278:21767-73; PMID:12676925; http://dx.doi.org/10.1074/jbc.M300229200.
28. Sørensen CS, Syljuåsen RG, Falck J, Schroeder T, Rönnstrand L, Khanna KK, et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003; 3:247-58; PMID:12676583; http://dx.doi.org/10.1016/S1535-6108(03)00048-5.
29. Balkwill F, Taylor-Papadimitriou J. Interferon affects both G1 and S + G2 in cells stimulated from quiescence to growth. Nature 1978; 274:798-800; PMID:683317; http://dx.doi.org/10.1038/274798a0.
30. Lundblad D, Lundgren E. Block of glioma cell line in S by interferon. Int J Cancer 1981; 27:749-54; PMID:6169666; http://dx.doi.org/10.1002/ijc. 2910270604.
31. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell 2006; 17:1583-92; PMID:16436515; http://dx.doi.org/ 10.1091/mbc.E05-09-0858.
32. Choudhury A, Cuddihy A, Bristow RG. Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair and the proteasome. Semin Radiat Oncol 2006; 16:51-8; PMID:16378907; http://dx.doi.org/10.1016/j. semradonc.2005.08.007.
33. Zhang YW, Brognard J, Coughlin C, You Z, Dolled-Filhart M, Aslanian A, et al. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress. Mol Cell 2009; 35:442-53; PMID:19716789; http://dx.doi.org/10.1016/j.molcel.2009.06.030.
34. Arora V, Cheung HH, Plenchette S, Micali OC, Liston P, Korneluk RG. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J Biol Chem 2007; 282:26202-9; PMID:17613533; http://dx.doi.org/10. 1074/jbc.M700776200.
35. Galvan V, Kurakin AV, Bredesen DE. Interaction of checkpoint kinase 1 and the X-linked inhibitor of apoptosis during mitosis. FEBS Lett 2004; 558:57-62; PMID:14759516; http://dx.doi.org/10.1016/S0014-5793(03)01488-1.
36. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1:2315-9; PMID:17406473; http://dx.doi.org/10.1038/nprot.2006.339.